Inhibition of induced-hepatic cancer in vivo through IQGAP1-shRNA gene therapy and modulation of TRAIL-induced apoptosis pathway

Overview of attention for article published in Frontiers in oncology, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 24,875 followers.

Inhibition of induced-hepatic cancer in vivo through IQGAP1-shRNA gene therapy and modulation of TRAIL-induced apoptosis pathway https://t.co/hgg0NmPl26

24 Oct 2022

Reply Repost Favourite

New article: Inhibition of induced-hepatic cancer in vivo through IQGAP1-shRNA gene therapy and modulation of TRAIL-induced apoptosis pathway https://t.co/WpvmQ0gwWE #livercancer #oncology https://t.co/jsbjZm4il5

24 Oct 2022

Reply Repost Favourite

Inhibition of induced-hepatic cancer in vivo through IQGAP1-shRNA gene therapy and modulation of TRAIL-induced apoptosis pathway: Background, Liver cancer is the deadliest malignancy among common tumors. It is the top cause of… #oncology https://t.co/27VM

06 Oct 2022

Reply Repost Favourite

New research: Inhibition of induced-hepatic cancer in vivo through IQGAP1-shRNA gene therapy and modulation of TRAIL-induced apoptosis pathway: Background Liver cancer is the deadliest malignancy among common tumors. It is the top cause of… https://t.co/D

05 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.